ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $20,511,000 | +194.1% | 763,896 | +77.1% | 0.02% | +150.0% |
| Q4 2018 | $6,974,000 | -70.3% | 431,314 | -61.9% | 0.01% | -25.0% |
| Q3 2018 | $23,486,000 | +179.7% | 1,131,348 | +105.8% | 0.01% | +33.3% |
| Q2 2018 | $8,396,000 | -16.5% | 549,824 | +22.9% | 0.01% | -14.3% |
| Q1 2018 | $10,054,000 | -45.1% | 447,439 | -26.5% | 0.01% | -41.7% |
| Q4 2017 | $18,322,000 | -40.2% | 608,500 | -25.2% | 0.01% | -42.9% |
| Q3 2017 | $30,637,000 | +272.4% | 813,300 | +175.8% | 0.02% | +250.0% |
| Q2 2017 | $8,226,000 | -22.0% | 294,935 | -3.8% | 0.01% | -25.0% |
| Q1 2017 | $10,542,000 | +24.1% | 306,629 | +4.1% | 0.01% | +33.3% |
| Q4 2016 | $8,494,000 | -10.1% | 294,533 | -0.9% | 0.01% | 0.0% |
| Q3 2016 | $9,449,000 | -24.1% | 297,059 | -22.5% | 0.01% | -40.0% |
| Q2 2016 | $12,446,000 | +22.2% | 383,440 | +5.3% | 0.01% | +25.0% |
| Q1 2016 | $10,186,000 | -20.8% | 364,302 | +0.9% | 0.01% | -20.0% |
| Q4 2015 | $12,866,000 | +6.5% | 360,909 | -1.2% | 0.01% | +11.1% |
| Q3 2015 | $12,086,000 | -20.4% | 365,469 | +0.8% | 0.01% | -18.2% |
| Q2 2015 | $15,190,000 | +62.8% | 362,701 | +26.7% | 0.01% | +57.1% |
| Q1 2015 | $9,333,000 | +4.4% | 286,375 | +1.7% | 0.01% | +16.7% |
| Q4 2014 | $8,942,000 | +14.7% | 281,626 | -10.6% | 0.01% | 0.0% |
| Q3 2014 | $7,796,000 | -13.4% | 314,870 | -21.0% | 0.01% | 0.0% |
| Q2 2014 | $9,007,000 | -6.4% | 398,723 | +0.9% | 0.01% | -14.3% |
| Q1 2014 | $9,618,000 | +1.4% | 395,325 | +4.2% | 0.01% | 0.0% |
| Q4 2013 | $9,483,000 | – | 379,488 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |